Search

Search Results

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  1825

  PDF: 564

  HTML: 15
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  724

  PDF: 367

  HTML: 12
• 

  Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

  Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

  29-12-2022

  1474

  PDF: 360

  HTML: 58

• Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

  Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

  11-09-2023

  584

  PDF: 324

  HTML: 8
• 

  Erythrodermic psoriasis treated with apremilast

  John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

  19-09-2016

  1831

  PDF: 816

  HTML: 595
• 

  Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

  Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

  21-11-2022

  1383

  PDF: 513

  HTML: 71

• Anisakis simplex and urticaria. What we know about its real incidence and management in dermatological settings?

  Sanja Javor, Donatella Bignardi, Matteo Borro, Cesare Massone

  29-08-2023

  449

  PDF: 315

  HTML: 7
• 

  Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

  Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

  21-11-2022

  1059

  PDF: 290

  HTML: 32
• 

  Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

  Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

  21-11-2022

  1300

  PDF: 306

  HTML: 16

• Skin-directed therapy and biologic response modifiers in mycosis fungoides

  Vieri Grandi, Virginia Alba Colantuono, Nicola Pimpinelli

  07-05-2024

  278

  PDF: 298
• 

  Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

  Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

  11-10-2017

  1165

  PDF: 550

  HTML: 132
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  827

  PDF: 415

  HTML: 16
• 

  Photocarcinogenicity of selected topically applied dermatological drugs: calcineurin inhibitors, corticosteroids, and vitamin D analogs

  Catharina Margrethe Lerche, Hans Christian Wulf

  e13

  14-09-2010

  1898

  PDF: 695

  HTML: 164
• 

  Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

  Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

  28-12-2021

  3897

  PDF: 509

  APPENDIX: 98

  HTML: 11
• 

  Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

  Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani

  14-06-2023

  661

  PDF: 340

  HTML: 13

• Treatment satisfaction among patients with psoriasis in Saudi Arabia

  Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

  15-04-2024

  377

  PDF: 120
• 

  The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination

  Georgi Tchernev, Simona Kordeva, Heily Kirilova, Valentina Broshtilova

  01-03-2023

  952

  PDF: 467

  HTML: 51
• 

  A retrospective comparative study of the efficacy and safety of two regimens of diphenylcyclopropenone in the treatment of recalcitrant alopecia areata

  Tueboon Sriphojanart, Saranya Khunkhet, Poonkiat Suchonwanit

  30-11-2017

  1850

  PDF: 738

  HTML: 246
• 

  Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

  Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

  23-11-2022

  1085

  PDF: 320

  HTML: 19
• 

  A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

  Lorry Aitkens, Joel Byrne, Charay Jennings-Dover, Kathryn Anne Potter

  29-12-2022

  656

  PDF: 317

  HTML: 59
• 

  Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

  Ashjan Alheggi, Raneem Alnutaifi, Manal Alkhonezan, Norah Almudawi, Renad Alsuhaibani, Philip Moons, Turki Aljuhani

  18-05-2023

  846

  PDF: 211

  APPENDIX S1: 79

  HTML: 3
• 

  Molluscum contagiosum eruption during therapy with methotrexate and abatacept: a clinical and dermoscopic case study

  Franca Taviti, Alessandra Calcinai, Federica Scarfì

  21-03-2022

  720

  PDF: 379

  HTML: 389
• 

  Certolizumab to treat hidradenitis suppurativa

  Asem Shadid, Saud Alobaida, Yousef Binamer

  27-10-2022

  1449

  PDF: 530

  HTML: 20
• 

  Late reaction to ustekinumab infusion

  Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

  e2

  09-09-2013

  3750

  PDF: 565

  HTML: 259
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  678

  PDF: 385

  HTML: 19